Screener
Dyne Therapeutics, Inc. DYN Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 7:25 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215702
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Cash and cash equivalents | $753,102 | $893,369 |
| Marketable securities | 219,054 | 217,193 |
| Prepaid expenses and other current assets | 48,871 | 16,025 |
| Total current assets | 1,021,027 | 1,126,587 |
| Property and equipment, net | 23,682 | 24,029 |
| Right-of-use assets | 19,652 | 20,742 |
| Restricted cash and other assets | 15,589 | 15,600 |
| Total assets | $1,079,950 | $1,186,958 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Dyne Therapeutics, Inc.'s total current assets?
- Dyne Therapeutics, Inc. (DYN) reported total current assets of $1.02B in Q1 2026.
- How has Dyne Therapeutics, Inc.'s total current assets changed year-over-year?
- Dyne Therapeutics, Inc.'s total current assets increased by 48.1% year-over-year, from $689.5M to $1.02B.
- What is the long-term trend for Dyne Therapeutics, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Dyne Therapeutics, Inc.'s total current assets has grown at a 26.4% compound annual growth rate (CAGR), from $349.09M to $1.13B.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Dyne Therapeutics, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude